Tech Company Financing Transactions
NuSirt Biopharma Funding Round
NuSirt Biopharma, operating out of Nashville, scored $6 million from Hatteras Venture Partners, Mountain Group Capital and TriStar Technology Fund.
Transaction Overview
Company Name
Announced On
5/14/2015
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series C
Investors
Hatteras Venture Partners (Lead Investor) (Clay Thorp)
TriStar Technology Fund (Brian Laden)
Proceeds Purpose
NuSirt will use this additional funding to expand research and development of its patented technology, which combines a naturally occurring amino acid, leucine, with existing pharmaceuticals. NuSirt's lead program targets Type 2 diabetes, and the company is in the process of completing a Phase 2A clinical trial enrolling more than 90 subjects. Funding will accelerate a separate product targeting non-alcoholic fatty liver disease (NAFLD), including steatohepatitis (NASH).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3835 Cleghorn Ave. 200
Nashville, TN 37215
USA
Nashville, TN 37215
USA
Phone
Website
Email Address
Overview
NuSirt Biopharma, Inc. has developed a breakthrough technology platform with the goal of enabling the use of natural compounds to create synergy with known pharmaceuticals to prevent and treat chronic diseases resulting from over-nutrition and aging.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Operating Officer
Barbara Cannon
Chief Scientific Officer
Michael Zemel
President
Joseph Cook
Browse more venture capital transactions:
Prev: 5/14/2015: Sureline Systems venture capital transaction
Next: 5/14/2015: Smarking venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs